Op. Dr. Cem Alay

- 2018 EBOD (European Board of Ophthalmology Diploma) sonucunda Fellow of European Board of Ophthalmology (FEBOph)

- 2020 International Council of Ophthalmology (ICO), The Visual Sciences Examination

- 2020 International Council of Ophthalmology (ICO), The Optics, Refraction & Instruments Examination

- 2021 International Council of Ophthalmology (ICO), Clinical Ophthalmology Examination

- 2021 International Council of Ophthalmology (ICO), Advanced Examination sonucunda Fellow of International Council of Ophthalmology (FICOph)

• Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUS – yardımcı araştırmacı
• Effıcacy and Safety of Ranibizumab for the Treatment of Choroidal Neovascularization due to Uncommon Cause: Twelve-Month Results of the MINERVA Study – yardımcı araştırmacı
• Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration (OCTAVE) – yardımcı araştırmacı

Ulusal Yayınları:

• Demirel S, Alay C, Batıoğlu F, Özmert E. İntravitreal ranibizumab tedavisi uygulanan retina ven dal tıkanıklığına bağlı makula ödemi olgularında görme keskinliğine etki eden prognostik faktörler. Retina -Vitreus 2014; 22(2): 103-109.

Uluslararası Yayınları:

• Yalçındağ FN, Alay C. Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis. F1000Res. 2013 Nov 15;2:245. doi: 10.12688/f1000research.2-245.v1. eCollection 2013.

Kiziltunc PB, Atilla H, Çalış F, Alay C. Comparison of surgical success for infantile esotropia and strabismus associated with neurological impairment. Strabismus. 2016 Sep;24(3):97-100. doi: 10.1080/09273972.2016.1210173.